BioSpace News Archive

Pharm Country

Provention Bio Resubmitting Biologics License Application for Delay of Clinical Type 1 Diabetes in At-Risk Individuals Following Type B Meeting with the FDA

Provention Bio, Inc. today announced its intent to resubmit the teplizumab Biologics License Application.

January 27, 2022
·
6 min read
Business

CooperCompanies Announces Release Date for First Quarter 2022

CooperCompanies announced it will release first quarter 2022 financial results on Thursday, March 3, 2022, at 4:15 PM ET.

January 27, 2022
·
1 min read
Getinge Launches State-of-the-Art Experience Center in New Jersey to Showcase Innovations in Healthcare and Medical Technology

Getinge launched the company’s new Experience Center located in Wayne, New Jersey with a special virtual event involving leaders from healthcare, technology and government.

January 27, 2022
·
4 min read
Business

AbCellera to Report Full Year 2021 Financial Results on February 24, 2022

AbCellera (Nasdaq: ABCL) announced today that it will report full year 2021 financial results after market close on Thursday, February 24, 2022 and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

January 27, 2022
·
1 min read
BioMidwest

Kaman Composites Expands Medical Imaging Programs With Mirion Technologies

Kaman Composites – Vermont, Inc., an indirect, wholly owned subsidiary of Kaman Corporation, announces the expansion of its medical imaging program through the recent new partnership with Mirion Technologies, a major medical equipment manufacturer.

January 27, 2022
·
3 min read
Business

PerkinElmer Board Declares Quarterly Dividend - Jan 27, 2022

The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of $0.07 per share of common stock January 27, 2022.

January 27, 2022
·
1 min read
Business

Electromed, Inc. Schedules its Second Quarter Fiscal 2022 Financial Results Conference Call for February 8, 2022 at 5:00 p.m. ET

Electromed, Inc. today announced that it will issue its financial results press release for the fiscal 2022 second quarter ended December 31, 2021, on Tuesday, February 8, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.

January 27, 2022
·
1 min read
Business

TYME Technologies, Inc. to Host Conference Call and Webcast on Friday, February 11, at 8:30 AM ET

TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that the Company will report its third quarter 2022 financial results on Friday, February 11, 2022, at 8:30 AM ET.

January 27, 2022
·
2 min read
Job Trends

Johnson & Johnson to Participate in Citi’s 2022 Virtual Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in Citi’s 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

January 27, 2022
·
1 min read
Deals

Ocugen, Inc. Signs Letter of Intent to Acquire Vaccine Manufacturing, R&D Hub in Ontario, Canada

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing breakthrough gene therapies and vaccines, announced that it has signed a non-binding letter of intent (LOI) with Liminal BioSciences, Inc.

January 27, 2022
·
9 min read